Physician profile
Isabel A Freeman
NPI 1295318301
$2,144.84
in general payments reported to CMS, 2019-2025
18 companies · $1,129 in 2025
The $1,129 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $13.55 · 2023: $758 · 2024: $244 · 2025: $1,129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,142 · Travel and Lodging: $889 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,142.18 |
| Travel and Lodging | $889.11 |
| Education | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $664.31 | 2025 | |
| Arthrex, INC. | $485.80 | 2023 | |
| Curonix LLC | $253.01 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Coastal Medical Technologies LLC | $212.10 | 2023-2025 | |
| Baxter Healthcare | $136.76 | 2025 | Seprafilm, Tisseel, Adept |
| Astrazeneca Pharmaceuticals LP | $72.86 | 2025 | Imfinzi, Enhertu |
| Integra Lifesciences Corporation | $42.32 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Glaxosmithkline, LLC. | $40.63 | 2025 | Zejula, Jemperli |
| Janssen Biotech, INC. | $40.47 | 2025 | Darzalex, Tecvayli, Rybrevant |
| Eisai INC. | $33.58 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $29.89 | 2025 | Libtayo |
| Spr Therapeutics, INC | $26.26 | 2024 | Sprint Pns System |
| Astellas Pharma US INC | $20.56 | 2025 | Vyloy |
| Vericel Corporation | $20.27 | 2024 | Maci |
| Bayer Healthcare Pharmaceuticals INC. | $17.93 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $17.86 | 2023 | Wegovy |
| Kerecis Limited | $16.68 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Stimwave Technologies Incorporated | $13.55 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isabel Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.